ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease causing irreversible lung scarring and loss of pulmonary function. IPF Patients suffer from a high rate of pulmonary infections and acute exacerbations of disease that further contribute to pulmonary decline. Low expression of the ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Hrusch, Cara L., Manns, Stephenie T., Bryazka, Dana, Casaos, Joshua, Bonham, Catherine A., Jaffery, Mohammad R., Blaine, Kelly M., Mills, Kathleen A.M., Verhoef, Philip A., Adegunsoye, Ayodeji O., Williams, Jesse W., Tjota, Melissa Y., Moore, Tamson V., Strek, Mary E., Noth, Imre, Sperling, Anne I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681437/
https://www.ncbi.nlm.nih.gov/pubmed/28488693
http://dx.doi.org/10.1038/mi.2017.42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681437/
https://www.ncbi.nlm.nih.gov/pubmed/28488693
http://dx.doi.org/10.1038/mi.2017.42

Ejemplares similares